Introduction
Single photon emission computed tomography (SPECT) is routinely used for the localization of the epileptogenic focus in patients undergoing presurgical evaluation for medically refractory epilepsy. Localization provided by the visual analysis of interictal and ictal SPECT images has been reported to be concordant with other modalities like magnetic resonance imaging (MRI) and Video-EEG (VEEG) in $90% of patients with temporal lobe epilepsy and $60-70% of patients with extratemporal lobe epilepsy. [1] [2] [3] [4] [5] [6] [7] [8] [9] Accuracy of the information provided by the SPECT studies can be further enhanced by the use of more objective analytical methods like subtraction ictal SPECT co-registered to magnetic resonance imaging (SISCOM) and statistical parametric mapping (SPM). [10] [11] [12] [13] [14] Accordingly, SPECT is considered an essential component of presurgical evaluation protocol for medically refractory epilepsy and many centers, especially in the developed countries, routinely undertake SPECT studies for all such patients. 15 However, it is known that SPECT usually provides concordant information in patients whose ictal onset zone can otherwise be well localized with the help of MRI and VEEG data. In such patients, obtaining additional concordant information with the help of SPECT is generally unnecessary. In contrast, SPECT might be helpful in those patients where other tests especially scalp VEEG and MRI are nonlocalizing and an unequivocal ictal onset zone cannot be clearly delineated. Though these are the patients most likely to be benefited by SPECT studies, surprisingly very little information is available regarding the exact utility of SPECT in this group of patients. Previous studies have either evaluated the localizing value of SPECT in relation to other tests or its utility in predicting postoperative seizure outcome. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Very few studies have evaluated the utility of SPECT in influencing the surgical decisionmaking. [18] [19] [20] These studies have also shown inconsistent results mainly because of the heterogeneous study subjects and varied study methods. Moreover, no information is available regarding its utility in influencing decision making in different epilepsy subgroups.
As performing a SPECT study especially an ictal SPECT is a labor intensive and costly proposition, its cost-effective utilization is important particularly in developing countries where the optimal use of limited resources is essential for the wider benefit of the community. Performing the SPECT studies for all the patients undergoing presurgical evaluation is neither necessary nor feasible. Gains of a SPECT study can be maximized in a costeffective manner by restricting its use in those patients where it is likely to add to decision making and avoiding in patients where source localization can be achieved with basic tests like VEEG and MRI. Hence, predicting the utility of the SPECT study in a given patient is important for more scientific and cost-effective utilization.
With this background, we undertook this study with the following objectives: (1) to study the utility of interictal and ictal SPECT studies in influencing the surgical decision making for the patients with medically refractory epilepsy; (2) to identify the characteristics of the patients who are likely to be benefited with the use of SPECT studies so as to develop an approach towards its cost-effective utilization.
Methods

Study setting
All the patients with medically refractory epilepsy attending the R. Madhvan Nayar Center for Comprehensive Epilepsy Care, Trivandrum, Kerala undergo a standard stepwise presurgical evaluation. 21 As the first step, all such patients are subjected to high resolution 1.5 T MRI, long-term VEEG monitoring and neuropsychological evaluation. If these basic tests provide unequivocal localizing and concordant information, enabling to generate the hypothesis regarding the probable epileptogenic zone and subsequent surgical decision-making, then further evaluation is not performed. However, if the information obtained from these basic tests is nonlocalizing or discordant, failing to provide a clear hypothesis for further decision making, then such patients are typically subjected to functional imaging [SPECT and/or positron emission Tomography (PET)] followed by intracranial monitoring, if required. Decisions for the SPECT studies are usually made at the end of the VEEG monitoring or during the comprehensive patient management conference, by a team comprising of epileptologists and neuroradiologists when a consensus opinion decides that the further evaluation is needed and is feasible. Decision to undertake functional imaging and the nature of the imaging (PET or SPECT) is typically individualized according to the baseline information and also to some extent influenced by the financial condition of the patient.
Subjects
During the period from January 2004 to December 2008, a total of 2702 patients underwent VEEG monitoring. Out of these, 61 patients with nonlocalizing or discordant baseline data underwent interictal and ictal SPECT studies. Demographic and clinical details of these patients were retrospectively retrieved from the database maintained at the epilepsy center. The study was approved by the institute review board.
Long-term VEEG monitoring
All patients underwent long-term video-EEG monitoring utilizing standard 10-20 system of electrode placement with additional anterior temporal (T1, T2) electrodes. Sphenoidal electrodes were inserted in patients with suspected temporal lobe epilepsy who had nonlateralizing or discordant ictal electroclinical data. All the data were reviewed by the two epileptologists. At least two habitual seizures were recorded for every patient. The presence and distribution of interictal epileptiform discharges (IEDs) during wakefulness and sleep was assessed by visual analysis of a minimum of 5 min of data every hour during a 24-h period, by two epileptologists (CR and KR).
MRI evaluation
All patients underwent a 1.5 T MRI utilizing a standard protocol as described in detail previously. 22 The neuroradiologist attached to the epilepsy program (CK) interpreted the MRI and findings were prospectively recorded.
SPECT study
All the SPECT studies were performed during the long-term VEEG monitoring using 99m Tc-ethyl cysteinate dimer (ECD) as the radiotracer. Radiotracer was injected by trained nurses at the earliest appearance of either the clinical or EEG changes. Timing of the ictal injection was determined from the time of the first EEG change to the time when the plunger of syringe was fully depressed. SPECT studies were performed using dual-headed gamma camera system equipped with low energy high resolution collimators (LEHR). The data were acquired in a 128 Â 128 byte matrix over 360 degrees with 120 views, 25 s per view, obtained at 3-degree intervals using a circular orbit. The energy setting was 140 keV with a 15-20% window. Transaxial images were reconstructed using a Butterworth filter (power = 10, critical frequency 0.45, full width half-maximum [FWHM] = 6 mm) rebinned into a 128 Â 128 matrix with a 2Â zoom. Attenuation correction (Chang order 0, coefficient 0.11) was applied, and a standard series of contiguous images was created in the transaxial, coronal, sagittal, and transtemporal planes. The reconstructed system resolution was approximately 7 mm FWHM and was composed of cubic voxels with dimensions of 3.6 or 4.4 mm (depending on the image size) and images were visualized on the monitor. Ictal images were obtained within 1 h of radiotracer injection while interictal images were obtained after 24 h of seizure free period. Images were interpreted individually by a physician trained in nuclear medicine and another neuroradiologist who were blinded to the clinical data. Any discrepancy was solved by mutual consensus. Based upon the visual analysis of the interictal and ictal images, SPECT studies were classified as localizing (localized to one lobe or sublobar region), lateralizing (involvement of more than one lobes), nonlateralizing (normal or diffuse involvement), falsely localizing (localized to the lobe other than the actual site of seizure origin) and falsely lateralizing.
Analysis of data and decision making
After obtaining the necessary investigations, details of all the patients undergoing presurgical evaluation were discussed in the multidisciplinary patient management conference. All such discussions and further decisions were entered into the database. Reasons for undertaking SPECT study were also noted during the proceedings of patient management conference. For the purpose of this study, we retrospectively ascertained the following data from the charts: type of seizure and epilepsy syndrome, interictal and ictal EEG findings, MRI results, ictal injection time, and the type of seizure during the ictal injection (partial or secondarily generalized). Final lateralization and localization was decided by the combination of clinical data, seizure semiology, interictal and ictal EEG, MRI results, and in selected patients from the information obtained by intracranial monitoring and seizure freedom after surgery. According to the final localization we divided the patients into three groups: mesial temporal lobe epilepsy (MTLE), neocortical temporal lobe epilepsy (NTLE) and extratemporal lobe epilepsy. In patients with normal MRI, following features were considered to be suggestive of MTLE: history of febrile seizures in childhood, epigastric or psychic aura, predominantly automotor seizures with relative lack of clustering and secondary generalization, strictly anterior temporal interictal discharges and Type IA ictal pattern. 22 Features which were considered to be suggestive of neocortical temporal lobe epilepsy were: atypical initial precipitating injury like encephalitis, relatively early age of onset, auditory or vertiginous aura, hypomotor seizures with early head version and facial jerks, presence of seizure clustering, more frequent secondary generalization, mid-temporal or posterior temporal IEDs and Type II or Type III ictal pattern. [22] [23] [24] We judged the utility of the SPECT study by its ability to provide information over and above provided by the initial basic tests and thus helping in further decision-making. The further decision was either to undertake surgical excision or undertake intracranial monitoring. SPECT was considered to be useful if it obviated the need for intracranial monitoring or it influenced the feasibility and type of intracranial coverage in a given patient. All such discussions were noted in the proceedings of patient management conference. Team consensus during these proceedings was used to determine the utility of SPECT. In case of any uncertainty, all the data for the given patient were reviewed by the two epileptologists (CR and KR) to determine whether SPECT helped in further decision making.
Statistical analysis
We summarized the quantitative data as mean AE standard deviation (SD). Three different epilepsy groups were compared with regard to the ability of SPECT to provide the localizing and lateralizing information, its concordance with the final localization and its ability to influence the final decision making using Fisher's exact test. P value of <0.05 was considered significant.
Results
For the 61 patients (38 males, 23 females), who underwent SPECT study, mean duration of epilepsy was 15.7 AE 6.8 years and mean age at evaluation was 25.1 AE 8.3 years. Final diagnosis was MTLE in 22 patients, NTLE in 13 patients and extratemporal lobe epilepsy in 26 patients. Utility of the SPECT in providing localizing, and lateralizing information as well as its ability to add to the final decision-making in these three groups is presented in Table 1 .
[ ( ) T D $ F I G ] Mean injection time for MTLE group was 25.7 AE 13.1 s, for the NTLE group was 25.2 AE 8.6 s and for ETLE was 21.3 AE 11.7 s. There was no difference in the mean injection time and proportion of the generalized seizures during ictal SPECT among the three groups (Table 1) . SPECT provided concordant lateralizing information in $80% of the patients in each group. However, as compared to the patients with extratemporal lobe epilepsy, SPECT provided significantly more localizing information in patients with MTLE (77.3% vs 46.2%, p = 0.006) and NTLE (63.6 vs 46.2, p = 0.09). SPECT was considered to be helpful in further decision making in 17 (28%) patients. Details of all the patients where SPECT helped in further decision making is provided in Table 2 . It provided information over and above the one provided by the baseline tests and thus influenced the final decision making in a significantly higher number of patients with MTLE than extratemoral lobe epilepsy (50.0% vs 11.53%, p = 0.005).
Mesial temporal lobe epilepsy
The patients with TLE could be divided into three broad groups depending upon the baseline characteristics: patients with unilateral mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE-HS) and nonlocalizing ictal data (Group 1, n = 13), those with MTLE and normal MRI (Group 2, n = 07), and those with dual pathology (Group 3, n = 2). SPECT was particularly useful for decisions making in group 1 as compared to group 2 (84.6% vs 0, p < 0.003). The 13 patients in the first group had all the data (clinical history, interictal EEG and MRI) concordant for unilateral MTLE-HS except the ictal recordings (Table 2 ; Fig. 1 ). Ictal semiology and ictal EEG in these patients were either discordant or nonlateralizing. In ten patients, ictal SPECT provided the localization which was concordant to the majority of data. These patients were selected for anterior temporal lobectomy on the basis of additional information provided by SPECT studies, thus obviating the need for depth monitoring. Eight out of these 10 patients became seizure free following surgery; one had persistent auras but no seizures while remaining one patient had no benefit with surgery. In remaining three patients, SPECT provided nonlocalizing information. Two of the patients in MTLE group, had unilateral hippocampal sclerosis with contralateral ictal onsets on scalp EEG, so called ''wasted hippocampus syndrome''. 25 SPECT showed ipsilateral localization in one and contralateral localization in the other patient. The patient in whom it showed contralateral localization, the radiotracer was injected after 45 s of ictal onset (Fig. 2) . This patient underwent bilateral hippocampal depth monitoring which confirmed the seizure origin from the side of hippocampal sclerosis. Both the patients became seizure free following anterior temporal lobectomy. In the second group with normal MRI, SPECT showed concordant localization in all the patients. However, it failed to provide any additional information over and above that provided by the VEEG monitoring. Out of the seven patients, two patients underwent surgery, three opted for the medical management and two are awaiting surgery. One patient became seizure free following surgery while other had no benefit. Two patients with dual pathology and temporal lobe epilepsy had calcified neurocystecircus granuloma in addition to the hippocampal sclerosis, one at the ipsilateral left superior temporal gyrus and other at the contralateral occipital lobe. SPECT showed the localization in relation to hippocampal sclerosis in both the patients. In the first patient, it was considered as false localization since all the other data indicated towards the superior temporal gyrus as the site of seizure origin. The second patient became seizure free following anterior temporal lobectomy (ATL).
Neocortical temporal lobe epilepsy
Out of the 13 patients with NTLE, six had normal or equivocal MRI findings, five had single lesion and equivocal ictal EEG while two had dual pathology. Three out of the five patients with single lesions showed SPECT localization in relation to the lesion and were selected for the surgery. SPECT was nonlocalizing in the remaining two patients. Out of the six patients with normal MRI, three showed SPECT localization to the lateral temporal lobe while three showed both mesial and lateral temporal hyper perfusion on ictal SPECT. In all these cases SPECT was not considered to provide any additional information and thus influence the final decisionmaking. While three of these patients underwent further intracranial monitoring and subsequent neocortical resection, others are awaiting further evaluation or opted for the medical management. SPECT did not provide information sufficient for the further decision making in two patients with dual pathologies, one with right hemispheric atrophy, right MTS and right occipital gliosis and other with left parietal and temporal dysplasias.
Extratemporal lobe epilepsy
Extratemporal lobe epilepsy patients could be divided into two broad groups: patients with normal MRI (Group 1, n = 15), and those with multiple or large hemispheric lesions where the unequivocal ictal onset zone could not be determined (Group 2, n = 11). SPECT was considered to be useful in only three patients: one with normal MRI and occipital epilepsy where SPECT results were useful in reducing the extent of intracranial coverage. Details of other two patients along with all the other patients where SPECT was considered to be useful in decision-making are presented in Table 2 (Fig. 3) . Importantly, in five (19.2%) of patients with ETLE, SPECT provided false localization to the ipsilateral temporal lobe suggesting a seizure propagation rather than origin (Fig. 4) .
Discussion
Our results indicate that SPECT provides additional information and is helpful in making decision about epilepsy surgery in a selected group of patients. Overall, SPECT provided additional information in about a quarter of our patients. SPECT is especially useful in patients with MTLE and uncertain ictal localization and those with widely spaced dual pathologies. Our results also show that its utility in patients with normal MRI is rather limited.
In our patients, SPECT provided concordant lateralizing information in $80% of the patients with all type of epilepsies and localizing information in $80% of patients with temporal lobe epilepsy and $45% of patients with extratemporal lobe epilepsy. These finding are similar to numerous previous studies showing high degree of concordance between SPECT and other investigations. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] However, our results also demonstrate that actual utility of SPECT in providing the additional information over and above the one provided by the other baseline investigations is rather limited. Very few studies have evaluated the actual utility of SPECT in influencing the surgical decision-making. A recent study with 321 patients showed that focal findings on the MRI or EEG were the most important in influencing the surgical decision making while SPECT did not contribute to the decision-making. 18 Other investigators have also questioned the utility of the SPECT in temporal lobe epilepsy. 19 Similarly, in another prospective study, the localized results on SISCOM influenced the decision making in only one third of the patients. 20 Our results further extend these findings by identifying the subgroup of the patients where SPECT can be really useful in further decision-making, thus paving the way for the more cost-effective utilization of this modality. SPECT was found to be most useful in patients with lesional TLE and nonlocalizing electrophysiological data. MTLE associated with hippocampal sclerosis is a heterogeneous entity, with variable electro-clinical characteristics. 26 Approximately one-third of patients with lesional TLE may have nonlocalizing ictal rhythms. 24 By providing additional concordant information, SPECT can potentially obviate the need for intracranial monitoring in this group of patients. One can argue that these patients may be selected for temporal lobectomy even without the ictal recordings. However, the present day epilepsy surgery calls for the concordant information from multiple sources to maximize the chances of seizure freedom. In this regard, SPECT does have a potential utility in this group of patients. SPECT may also be potentially useful in patients with ''wasted hippocampus syndrome'', provided the radiotracer is injected sufficiently early. However, this aspect requires further study in a larger group of patients. We did not find SPECT to be useful for further decision-making in patients with normal MRI and either MTLE or NTLE. Major issue in this group of patients is to differentiate MTLE from NTLE and TLE from ''temporal plus epilepsies'' or pseudotemporal epilepsy. 27 Due to the extensive connections of the temporal lobe with other limbic structures and with parieto-occipital regions, seizures originating from these areas can rapidly propagate to the temporal lobe and these patients may present as temporal lobe epilepsy. As the perfusion patterns also follow the ictal patterns, SPECT may provide a false localization to the temporal lobe in these patients. 5 Similarly, an ictal SPECT is more likely to depict the widespread hyperperfusion involving the limbic network, 28, 29 and is unlikely to differentiate the seizures arising form the operculoinsular or basifrontal region from those originating at mesial or lateral temporal regions, in a given patient. These patients can either be selected noninvasively without the need for SPECT or can be subjected to intracranial monitoring depending upon the original hypothesis. 22 Similarly, we did not find it to be useful in patients with extratemporal lobe epilepsy and normal MRI. SPECT can provide reliable lateralizing information in this group of patients. However, localizing value in this subset of patients is rather limited with high false positive results. All of these patients showed false localization to ipsilateral temporal lobe suggesting seizure propagation rather than the site of seizure origin, suggesting that SPECT results should be evaluated in the context of other data.
Other potential group where SPECT can provide the useful information is the patients with widely spaced dual pathologies. It is not uncommon to find incidental but potentially epileptogenic calcified lesions in countries endemic for neurocystecercosis. 30, 31 SPECT can obviate the need for intracranial monitoring in these patients when other data is nonlocalizing. Similarly, it could also be useful in patients with tuberous sclerosis with multiple tubers.
We acknowledge the following limitations of our study. There is a potential selection bias, as SPECT was undertaken only in patients where the initial data was nonlocalizing and in whom further evaluation was considered worthwhile. Many patients were excluded from the further evaluation based upon the baseline data. However, it will be difficult to assume that SPECT is likely to provide any extra information in these patients. Thus our patients are fairly representative of the group where the SPECT is likely to be considered useful. Similarly, it is difficult to ascertain that whether the use of the other analytical methods like SISCOM or SPM would have altered the results. Although SISCOM and SPM have shown to have more localizing value than the visual analysis, [10] [11] [12] [13] [14] their utility in influencing the decision making has not been compared. Similar to our results, use of the SISCOM was found to contribute to the decision-making in only one-third of the patients. 20 One more limitation may be the non-availability of the final localization in few patients which can be proven only by the intracranial monitoring or seizure freedom following surgery. However, our aim was to study the utility of SPECT in surgical decision-making in a clinical setting and not to study its final localizing value. For this purpose, the consensus decision-making at the multidisciplinary patient management conference is a validated method used across all the major epilepsy surgery centers. 32 It needs to be emphasized that in spite of proven validity, the results represent the decision-making process at our center and might slightly differ across the centers. Similarly, ability to detect significant differences between different subgroups may be limited due to the small number of patients in this study and results needs to be validated in a larger group of patients. Presurgical evaluation is a cost-intensive procedure where multiple tests are undertaken to obtain the best possible concordance so as to maximize the chances of seizure freedom. Undertaking an additional test is likely to escalate the cost of the overall evaluation by several folds. The radiotracers used in the SPECT study have short half lives of 4-6 h and multiple fillings are often needed for the successful completion of an ictal SPECT. These radiotracers are costly and not freely available for many centers in India. Moreover, an ictal SPECT requires the constant presence of an EEG technologist and a trained nurse to ensure the timely injection of the radiotracer. All these factors escalate the cost of a SPECT study and consequently of the overall presurgical evaluation. At our center undertaking a successful ictal SPECT costs approximately Indian Rupees 8000-10,000 (Euro, 150-200), which is beyond the reach of many patients. This calls for the selective utilization of the SPECT where it is likely to provide additional information and avoiding it where the information is likely to be redundant. Our results are helpful in developing a cost effective strategy in countries with limited resources for the better utilization of SPECT during presurgical evaluation.
Conclusions
We conclude that SPECT is potentially useful in few selected patients where it can influence the further decisions making while it is a redundant investigation in others. By restricting its use in those patients where it has a high probability of influencing the further decision making rather than using it for all the patients, a cost effective strategy can be evolved especially in countries with limited resources.
